Christopher Poole
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Cancer Research top 1%
- Breast Cancer Treatment Studies
Papers in
- Oncology 27
- Cancer Treatment and Pharmacology 12
- HER2/EGFR in Cancer Research 6
- PARP inhibition in cancer therapy 5
-
- Breast Cancer Treatment Studies 21
- Cancer Genomics and Diagnostics 5
- Co-authors
- Janet Dunn (28 shared papers)Andrea Marshall (7 shared papers)Annie Young (2 shared papers)Ajay K. Kakkar (2 shared papers)Oliver Chapman (2 shared papers)Helena Earl (26 shared papers)Daniel Rea (14 shared papers)Jeremy Dale (1 shared paper)
- Journals
- Journal of Clinical Oncology (17 papers)Annals of Oncology (5 papers)Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)The Lancet Oncology (3 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Christopher Poole
65 papers receiving 3.9k citations
Christopher Poole's Hit Papers
Peers
Comparison fields: 5 of 112
- Internal Medicine 809
- Cancer Research 962
- Oncology 1.5k
- Reproductive Medicine 366
- Emergency Medical Services 175
Countries citing papers authored by Christopher Poole
This map shows the geographic impact of Christopher Poole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Poole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Poole more than expected).
Fields of papers citing papers by Christopher Poole
This network shows the impact of papers produced by Christopher Poole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Poole. The network helps show where Christopher Poole may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Poole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) Hit paper breakdown → | 2018 | 904 |
| 2 | Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial Hit paper breakdown → | 2014 | 452 |
| 3 | 2013 | 310 | |
| 4 | 2007 | 174 | |
| 5 | 2016 | 153 | |
| 6 | 2018 | 149 | |
| 7 | 1996 | 141 | |
| 8 | 2006 | 140 | |
| 9 | 2016 | 121 | |
| 10 | 2012 | 119 | |
| 11 | 2002 | 112 | |
| 12 | 2011 | 103 | |
| 13 | 2010 | 98 | |
| 14 | 1991 | 96 | |
| 15 | 2014 | 88 | |
| 16 | 2012 | 60 | |
| 17 | 2016 | 59 | |
| 18 | 2002 | 56 | |
| 19 | 2013 | 55 | |
| 20 | 2012 | 51 |
About Christopher Poole
Christopher Poole is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 67 papers that have together received 4.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (21 papers), Cancer Treatment and Pharmacology (12 papers), HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (6 papers), Ovarian cancer diagnosis and treatment (5 papers), Cancer Genomics and Diagnostics (5 papers), PARP inhibition in cancer therapy (5 papers) and Breast Lesions and Carcinomas (4 papers). The work is most often cited by research in Internal Medicine (809 citations), Cancer Research (962 citations), Oncology (1.5k citations), Reproductive Medicine (366 citations) and Emergency Medical Services (175 citations). Christopher Poole has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Janet Dunn, Andrea Marshall, Annie Young, Ajay K. Kakkar, Oliver Chapman, Helena Earl, Daniel Rea, Jeremy Dale, Gary H. Lyman and Catherine St. Hill. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancer Chemotherapy and Pharmacology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.